首页 | 本学科首页   官方微博 | 高级检索  
     


Aspirin for Primary Prevention in Patients with Type 2 Diabetes
Affiliation:1. From the Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida;2. Brigham and Women''s Hospital, Harvard Medical School, Boston, Massachusetts;3. Department of Biostatistics and Informatics, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin;4. Baylor Medical College, Waco, Texas.;1. From the Division of Endocrinology and Diabetes, The Robert Larner, MD College of Medicine at The University of Vermont, Burlington, Vermont;2. Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.;1. From the Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan.;1. From the Department of Radiology, Seoul National University Hospital, Seoul, Korea;2. Department of Radiology, Seoul National University College of Medicine, Seoul, Korea;3. Department of Radiology, Kangbuk Samsung Hospital, Seoul, Korea;4. Department of Radiology, Anam Hospital, Korea University College of Medicine, Seoul, Korea;5. Department of Radiology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, Korea;6. Department of Radiology, Gangnam Center, Seoul National University Hospital Healthcare System, Seoul, Korea;7. Department of Radiology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.;1. From the Beijing Key Laboratory of Diabetes Mellitus Prevention and Research, Department of Endocrinology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.;2. These authors contributed equally to this article.;1. From the Center for Value-Based Insurance Design, Ann Arbor, Michigan;2. Eli Lilly and Company, Indianapolis, Indiana.
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号